Spencer R. Berthelsen - Jun 20, 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Spencer R. Berthelsen
Stock symbol
IONS
Transactions as of
Jun 20, 2023
Transactions value $
$320,288
Form type
4
Date filed
6/22/2023, 05:17 PM
Previous filing
Jul 19, 2022
Next filing
Jul 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Options Exercise $320K +11.3K +8.73% $28.47 140K Jun 20, 2023 Direct F1
holding IONS Common Stock 70 Jun 20, 2023 by Daughter F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Non-Qualified Stock Option (right to buy) Options Exercise $0 -11.3K -100% $0.00* 0 Jun 20, 2023 Common Stock 11.3K $28.47 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2023
F2 The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.